Funding Received
$1.4 Million in 1 Round from 4 Investors
Most Recent Funding
$1.4 Million on August 14, 2009 / Undisclosed Round
Founded:
1994
Headquarters:
Laval, QC
Description:
Biosyntech is engaged in the development of biotherapeutic thermogels for tissue repair and the delivery of therapeutic agents.
Categories:
Biotechnology
Website:
http://www.biosyntech.com

Detailed Description

Update

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. Its technology platform is BST-Gel, a family of hydrogels based on chitosan, a natural biopolymer derived from crustacean shells. The company’s lead products in clinical trials include BSTCarGel for cartilage repair; BST-DermOn for wound healing; and BST-InPod for the treatment of chronic pain due to plantar fat pad atrophy in the heel and forefoot.

Biosyntech has a collaboration with Nicholas Piramal India, Ltd. to involve in the clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. The company was incorporated in 1994 and is headquartered in Laval, Canada.

Investors (4)

Update

Offices/Locations (1)

Update
  • HQ

    475 Armand-Frappier Blvd.

    Laval, QC H7V 4B3

    CAN

Images (1)

Update
  • 68c813bdd0f8bed2441c984f879d2279